See, Test & Treat is a free, pathologist-led cancer screening and health education program that brings the power of diagnostic medicine to medically underserved populations with the goals of:
- Addressing health disparities by reducing barriers to care for medically underserved people through health care system partnerships.
- Empowering prevention by delivering dignified cervical and breast cancer screenings—with same-day or prompt results—with a focus on health education.
- Connecting communities by linking patients and their families to a medical home and resources within their own communities.
In a single-day, culturally appropriate program, women receive a pelvic and clinical breast exam, a Pap test with same-day results, a screening mammogram with same-day or prompt results, connection to follow-up care, interpretive services, impactful health education, and translated educational materials to take home.
Program Expectations
The following are mandatory components every See, Test & Treat must provide:
- Free cervical and breast cancer screenings for uninsured or underinsured women
- Same-day results for cervical cancer screenings; results same-day (preferable) or within one week for breast cancer screenings
- Culturally, linguistically appropriate health education for your target communities
- Connection to care for any individual in need of follow-up services or treatment, regardless of health insurance status
Women’s Health Study
Recently released guidelines recommend that providers utilize primary HPV testing every five years—rather than co-testing with Pap smears—to conduct cervical cancer screenings. However, most studies conducted to support these recommendations were done in populations with good access to health care. Furthermore, some studies indicate the increased possibility of false negatives with primary HPV testing. These factors are creating hesitancy around implementation of the guidelines.
To further assess the possibility of discordant results between primary HPV and Pap tests, the CAP Foundation is requesting all grantees participate in a See, Test & Treat Women’s Health Study to be conducted from 2022 to 2025. The study will utilize data obtained from concurrent testing for high-risk human papilloma virus (HR-HPV) and cervical cytology (ie, co-testing) in the vulnerable populations served by See, Test & Treat and characterize discordant results in terms of histologic findings and high-risk HPV types.
Participation in the study entails the following:
- Co-testing (Pap + HPV) for all patients undergoing cervical cancer screening via your institution’s See, Test & Treat program
- Obtaining IRB approval for this study from your institution with the assistance of the Foundation
- Sharing de-identified data on individual patients
Participation is strongly encouraged but not mandatory to receive grant funding. Applicants are asked to indicate interest in study participation within their application.
Eligibility
Funding is open to CAP members in partnership with a 501(c)3 non-profit organization(s) to support programs taking place in the US. Note, award funding will only be made to a 501(c)3 organization.
Also, applicants must have the following in place before applying for a grant:
- Ability to screen at least 50 women per program
- Ability to support the four core program components
- A committed pathologist leader who is also a member of the CAP. The pathologist leader must be part of the on-site health care team providing services at the See, Test & Treat program.
All applicants will be considered regardless of age, race, gender, or national origin.
Funding Pathways
For the 2023 cycle, the CAP Foundation is excited to announce two funding pathways:
Single-Year Funding
New and repeat applicants are invited to apply for grants up to $20,000 to support eligible program expenses for 2023.
Repeat applicants (those who have successfully completed one or more grant cycles of See, Test & Treat) are expected to incorporate a decrease (up to 10% from previous year) in requested funding to gradually work toward program sustainability. Maintenance funding is available (by invitation only) to “repeat” grantees who:
- Have completed three grant cycles of See, Test & Treat (including successful execution of program and required reporting)
- Have screened at least 50 women per program
- Are requesting $8,000 or less in funding
Multiyear Funding
Multiyear funding (MYF) provides grant funding up to $50,000 over a three-year period. This funding option involves a shared financial commitment in which the hosting institution assumes an annual funding reduction of up to 10%. One to two MYF funding slots will be available in 2023. Eligibility is open to “repeat” grantees who:
- Have successfully completed at least one full cycle of See, Test & Treat (program plus outcomes reporting requirements over the last three years)
- Screened at least 50 women per program
Note, applicants not chosen for MYF are automatically placed in the application pool for single-year funding.